Skip to main content
Clinical Trials/NCT04221880
NCT04221880
Completed
N/A

Erector Spinae Plane Block Versus Perioperative Intravenous Lidocaine for Postoperative Pain Control in Patients Undergoing Thoracotomy: A Prospective, Randomized, Double-blind Controlled Clinical Trial

Ataturk University1 site in 1 country60 target enrollmentSeptember 29, 2021

Overview

Phase
N/A
Intervention
Bupivacaine Hcl 0.25% Inj
Conditions
Thoracic Diseases
Sponsor
Ataturk University
Enrollment
60
Locations
1
Primary Endpoint
Opioid Consumption
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Thoracotomy surgery is the most painful of all surgical procedures. Inadequate postoperative pain control in these patients may cause serious morbidity related to pulmonary, cardiovascular and emotional systems. Erector Spinae Plane Block (ESPB) was first described in 2016 and, it is frequently used for postoperative analgesia in thoracic surgery. Intravenous lidocaine exhibit analgesic activity through both the peripheral and central nervous system. Intravenous lidocaine has been shown to reduce postoperative pain intensity and accelerate postoperative recovery in many surgeries.

The investigators aimed to compare the effect of lidocaine infusion and erector spinae plane block on postoperative opioid consumption and pain scores.

Registry
clinicaltrials.gov
Start Date
September 29, 2021
End Date
March 15, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmet Murat Yayik

Medical Doctor

Ataturk University

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiologist's physiologic state I-III patients undergoing thoracotomy surgery

Exclusion Criteria

  • chronic pain, bleeding disorders, renal or hepatic insufficiency, non cooperative patient,
  • Patients with allergies to one of the drugs used in the study.

Arms & Interventions

Group ESPB

Ultrasound-guided erector spinae plane block with 20 ml %0.25 bupivacaine and Saline iv. bolus and infusion (same volume as Group Lidocaine)

Intervention: Bupivacaine Hcl 0.25% Inj

Group ESPB

Ultrasound-guided erector spinae plane block with 20 ml %0.25 bupivacaine and Saline iv. bolus and infusion (same volume as Group Lidocaine)

Intervention: Saline Solution intravenously

Group Lidocaine

1.5 mg / kg lidocaine iv. bolus and, 1.5mg / kg / h lidocaine iv. infusion and, Ultrasound-guided erector spinae plane block with 20 ml saline

Intervention: Saline Solution for Block

Group Lidocaine

1.5 mg / kg lidocaine iv. bolus and, 1.5mg / kg / h lidocaine iv. infusion and, Ultrasound-guided erector spinae plane block with 20 ml saline

Intervention: Lidocaine

Group Control

Ultrasound-guided erector spinae plane block with 20 ml saline and, Saline iv. bolus and infusion (same volume as Group Lidocaine)

Intervention: Saline Solution for Block

Group Control

Ultrasound-guided erector spinae plane block with 20 ml saline and, Saline iv. bolus and infusion (same volume as Group Lidocaine)

Intervention: Saline Solution intravenously

Outcomes

Primary Outcomes

Opioid Consumption

Time Frame: First 24 hours total opioid consumption

First 24 hours total fentanyl consumption with patient controlled analgesia

Secondary Outcomes

  • Visual analog pain score(Postoperative 24 hour)

Study Sites (1)

Loading locations...

Similar Trials